Evidence map›Paper›PMID 35756531›Full record

ArticleChemical science2022

Covalent labeling of a chromatin reader domain using proximity-reactive cyclic peptides.

Meng Yao Zhang, Hyunjun Yang, Gloria Ortiz, Michael J Trnka, Nektaria Petronikolou, Alma L Burlingame, William F DeGrado, Danica Galonić Fujimori

Abstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Recent advances in the development of therapeutic peptides.Trends in pharmacological sciences · 2023
    Review
  15. Non-histone binding functions of PHD fingers.Trends in biochemical sciences · 2023
    Review
  16. Chemical tools targeting readers of lysine methylation.Current opinion in chemical biology · 2023
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Meng Yao ZhangDepartment of Cellular and Molecular Pharmacology, University of California San Francisco San Francisco CA 94158 USA danica.fujimori@ucsf.edu.
Hyunjun YangDepartment of Pharmaceutical Chemistry, University of California San Francisco San Francisco CA 94158 USA.ORCID https://orcid.org/0000-0003-2524-2201
Gloria OrtizDepartment of Cellular and Molecular Pharmacology, University of California San Francisco San Francisco CA 94158 USA danica.fujimori@ucsf.edu.
Michael J TrnkaDepartment of Pharmaceutical Chemistry, University of California San Francisco San Francisco CA 94158 USA.
Nektaria PetronikolouDepartment of Cellular and Molecular Pharmacology, University of California San Francisco San Francisco CA 94158 USA danica.fujimori@ucsf.edu.
Alma L BurlingameDepartment of Pharmaceutical Chemistry, University of California San Francisco San Francisco CA 94158 USA.
William F DeGradoDepartment of Pharmaceutical Chemistry, University of California San Francisco San Francisco CA 94158 USA.
Danica Galonić FujimoriDepartment of Cellular and Molecular Pharmacology, University of California San Francisco San Francisco CA 94158 USA danica.fujimori@ucsf.edu.ORCID https://orcid.org/0000-0002-4066-9417

Funding

Deciphering the relationship between structure, dynamics and function in helical bundle proteinsR35GM122603 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WILLIAM DEGRADO · 2017 to 2026
$7.1M
A 600 MHz NMR console and cryoprobe for studies of macromolecules, drug discovery and cancer biomarkersS10OD023455 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GROSS, JOHN D · 2018 to 2018
$820k
NIGMS NIH HHS R35 GM122603NIH HHS S10 OD023455
6 · The paper itself

Abstract

Chemical probes for chromatin reader proteins are valuable tools for investigating epigenetic regulatory mechanisms and evaluating whether the target of interest holds therapeutic potential. Developing potent inhibitors for the plant homeodomain (PHD) family of methylation readers remains a difficult task due to the charged, shallow and extended nature of the histone binding site that precludes effective engagement of conventional small molecules. Herein, we describe the development of novel proximity-reactive cyclopeptide inhibitors for PHD3-a trimethyllysine reader domain of histone demethylase KDM5A. Guided by the PHD3-histone co-crystal structure, we designed a sidechain-to-sidechain linking strategy to improve peptide proteolytic stability whilst maintaining binding affinity. We have developed an operationally simple solid-phase macrocyclization pathway, capitalizing on the inherent reactivity of the dimethyllysine ε-amino group to generate scaffolds bearing charged tetraalkylammonium functionalities that effectively engage the shallow aromatic 'groove' of PHD3. Leveraging a surface-exposed lysine residue on PHD3 adjacent to the ligand binding site, cyclic peptides were rendered covalent through installation of an arylsulfonyl fluoride warhead. The resulting lysine-reactive cyclic peptides demonstrated rapid and efficient labeling of the PHD3 domain in HEK293T lysates, showcasing the feasibility of employing proximity-induced reactivity for covalent labeling of this challenging family of reader domains.

Identifiers

PMID35756531
PMCPMC9172573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.